Sustainability Report

Overview

The report covers Zuellig Pharma's 2022 sustainability performance across operations in 17 Asian markets. The company reports validated near-term science-based targets, including a 42% reduction in Scope 1 and 2 emissions and a 25% reduction in selected Scope 3 emissions by 2030. Total GHG emissions fell to 309,279 tCO2e, while the workforce totaled 12,399 staff. Bureau Veritas provided limited assurance over selected sustainability information.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services